Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

This is one of the first real-world multicenter studies in a predominantly adult white population showing that lebrikizumab is effective, safe and improves symptoms, QoL, and mental health in moderate-to-severe AD bio/JAKi-naïve and -experienced patients.

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-10-10
DOI
https://doi.org/10.1007/s13555-025-01550-8
Citations
6
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
12.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

Elisabetta Magnaterra, Francesco Bellinato, Roberta Giuffrida, Angelo Valerio Marzano et al.
6 citations
Dermatology and Therapy
Dermatology and Skin Diseases
12.03
article

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

Elisabetta Magnaterra, Francesco Bellinato, Roberta Giuffrida, Angelo Valerio Marzano, Simone Ribero, Massimo Gola, Alan Azzolini, Maddalena Napolitano, Flavia Pigliacelli, Maria Esposito, Luigi Gargiulo, Eugenia Veronica Di Brizzi, Giampiero Girolomoni, Mariateresa Rossi, Niccolò Gori, Carlotta Gurioli, Piergiorgio Malagoli, Paola Savoia, Luca Stingeni, Ilaria Trave, Teresa Grieco, Gianluca Avallone, Antonio Costanzo, Maria Mariano, Anna Balato, Maria Concetta Fargnoli, Paolo Calzari, Michela Ortoncelli, Elena Pezzolo, Cataldo Patruno, Anna Graziella Burroni, Camilla Chello, Serena Giacalone, Natale Schettini, Federica Veronese, Caterina Foti, Silvia Mariel Ferrucci, Alessandra Narcisi, Laura Bonzano, Alexandra Maria Giovanna Brunasso, Francesca Barei, Ketty Peris, Katharina Hansel, Antonio Portarapillo, Ersilia Tolino, Andrea Bombelli
article en
6 citations

Abstract

This is one of the first real-world multicenter studies in a predominantly adult white population showing that lebrikizumab is effective, safe and improves symptoms, QoL, and mental health in moderate-to-severe AD bio/JAKi-naïve and -experienced patients.

Dermatology and TherapyVol. 15(12)
Università Cattolica del Sacro Cuore (IT), University of Messina (IT), University of Verona (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Molise (IT), Humanitas University (IT), University of Milan (IT), University of Ferrara (IT), University of L'Aquila (IT), University of Perugia (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Ospedale di Bolzano (IT), IRCCS Policlinico San Donato (IT), Ospedale Sant Antonio (IT), Azienda USL di Bologna (IT), University of Campania "Luigi Vanvitelli" (IT), Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli (IT), San Gallicano Hospital (IT), Ospedale Policlinico San Martino (IT), Ospedale San Bortolo (IT), Villa Torri Hospital (IT), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), University of Brescia (IT), Sapienza University of Rome (IT), University of Bologna (IT)
Openalex Percentile: Top 1%
Dermatology and Skin Diseases
12.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.